{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["molecular role", "neuroinflammation", "neurological disorders", "neuroprotection", "therapeutic", "\u03b1-asarone", "\u03b2-asarone"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35204164", "DateRevised": {"Year": "2022", "Month": "02", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "29"}], "Language": ["eng"], "ELocationID": ["281", "10.3390/antiox11020281"], "Journal": {"ISSN": "2076-3921", "JournalIssue": {"Volume": "11", "Issue": "2", "PubDate": {"Year": "2022", "Month": "Jan", "Day": "29"}}, "Title": "Antioxidants (Basel, Switzerland)", "ISOAbbreviation": "Antioxidants (Basel)"}, "ArticleTitle": "Molecular Mechanisms and Therapeutic Potential of \u03b1- and \u03b2-Asarone in the Treatment of Neurological Disorders.", "Abstract": {"AbstractText": ["Neurological disorders are important causes of morbidity and mortality around the world. The increasing prevalence of neurological disorders, associated with an aging population, has intensified the societal burden associated with these diseases, for which no effective treatment strategies currently exist. Therefore, the identification and development of novel therapeutic approaches, able to halt or reverse neuronal loss by targeting the underlying causal factors that lead to neurodegeneration and neuronal cell death, are urgently necessary. Plants and other natural products have been explored as sources of safe, naturally occurring secondary metabolites with potential neuroprotective properties. The secondary metabolites \u03b1- and \u03b2-asarone can be found in high levels in the rhizomes of the medicinal plant <i>Acorus calamus</i> (L.). \u03b1- and \u03b2-asarone exhibit multiple pharmacological properties including antioxidant, anti-inflammatory, antiapoptotic, anticancer, and neuroprotective effects. This paper aims to provide an overview of the current research on the therapeutic potential of \u03b1- and \u03b2-asarone in the treatment of neurological disorders, particularly neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), as well as cerebral ischemic disease, and epilepsy. Current research indicates that \u03b1- and \u03b2-asarone exert neuroprotective effects by mitigating oxidative stress, abnormal protein accumulation, neuroinflammation, neurotrophic factor deficit, and promoting neuronal cell survival, as well as activating various neuroprotective signalling pathways. Although the beneficial effects exerted by \u03b1- and \u03b2-asarone have been demonstrated through in vitro and in vivo animal studies, additional research is required to translate laboratory results into safe and effective therapies for patients with AD, PD, and other neurological and neurodegenerative diseases."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Life Science, Graduate School, BK21 Program, Konkuk University, Chungju 27478, Korea."}, {"Identifier": [], "Affiliation": "Department of Biotechnology, Research Institute of Inflammatory Disease (RID), College of Biomedical and Health Science, Konkuk University, Chungju 27478, Korea."}], "LastName": "Balakrishnan", "ForeName": "Rengasamy", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Life Science, Graduate School, BK21 Program, Konkuk University, Chungju 27478, Korea."}], "LastName": "Cho", "ForeName": "Duk-Yeon", "Initials": "DY"}, {"Identifier": ["0000-0001-5755-8433"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Research Institute of Inflammatory Disease (RID), College of Biomedical and Health Science, Konkuk University, Chungju 27478, Korea."}], "LastName": "Kim", "ForeName": "In-Su", "Initials": "IS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research and Development, Sinil Pharmaceutical Co., Ltd., Seongnam-si 13207, Korea."}], "LastName": "Seol", "ForeName": "Sang-Ho", "Initials": "SH"}, {"Identifier": ["0000-0001-7041-1524"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Life Science, Graduate School, BK21 Program, Konkuk University, Chungju 27478, Korea."}, {"Identifier": [], "Affiliation": "Department of Biotechnology, Research Institute of Inflammatory Disease (RID), College of Biomedical and Health Science, Konkuk University, Chungju 27478, Korea."}], "LastName": "Choi", "ForeName": "Dong-Kug", "Initials": "DK"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Antioxidants (Basel)", "NlmUniqueID": "101668981", "ISSNLinking": "2076-3921"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Neurological Disorders: Public Health Challenges.  [(accessed on 5 October 2021)].  Available online:  https://www.who.int/publications/i/item/9789241563369."}, {"Citation": "MacDonald B.K., Cockerell O.C., Sander J.W.A.S., Shorvon S.D. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Pt 4Brain. 2000;123:665\u2013676. doi: 10.1093/brain/123.4.665.", "ArticleIdList": ["10.1093/brain/123.4.665", "10733998"]}, {"Citation": "Gorman A.M. Neuronal cell death in neurodegenerative diseases: Recurring themes around protein handling. J. Cell. Mol. Med. 2008;12:2263\u20132280. doi: 10.1111/j.1582-4934.2008.00402.x.", "ArticleIdList": ["10.1111/j.1582-4934.2008.00402.x", "PMC4514105", "18624755"]}, {"Citation": "Iuchi K., Takai T., Hisatomi H. Cell Death via Lipid Peroxidation and Protein Aggregation Diseases. Biology. 2021;10:399. doi: 10.3390/biology10050399.", "ArticleIdList": ["10.3390/biology10050399", "PMC8147787", "34064409"]}, {"Citation": "Jha S.K., Jha N.K., Kumar D., Ambasta R.K., Kumar P. Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration. Biochim. Biophys. Acta BBA\u2014Mol. Basis Dis. 2017;1863:1132\u20131146. doi: 10.1016/j.bbadis.2016.06.015.", "ArticleIdList": ["10.1016/j.bbadis.2016.06.015", "27345267"]}, {"Citation": "Jurcau A. Insights into the Pathogenesis of Neurodegenerative Diseases: Focus on Mitochondrial Dysfunction and Oxidative Stress. Int. J. Mol. Sci. 2021;22:11847. doi: 10.3390/ijms222111847.", "ArticleIdList": ["10.3390/ijms222111847", "PMC8584731", "34769277"]}, {"Citation": "Deture M.A., Dickson D.W. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol. Neurodegener. 2019;14:32. doi: 10.1186/s13024-019-0333-5.", "ArticleIdList": ["10.1186/s13024-019-0333-5", "PMC6679484", "31375134"]}, {"Citation": "Chen G.F., Xu T.H., Yan Y., Zhou Y.R., Jiang Y., Melcher K., Xu H.E. Amyloid beta: Structure, biology and structure-based therapeutic development. Acta Pharmacol. Sin. 2017;38:1205\u20131235. doi: 10.1038/aps.2017.28.", "ArticleIdList": ["10.1038/aps.2017.28", "PMC5589967", "28713158"]}, {"Citation": "Sanabria-Castro A., Alvarado-Echeverr\u00eda I., Monge-Bonilla C. Molecular Pathogenesis of Alzheimer\u2019s Disease: An Update. Ann. Neurosci. 2017;24:46. doi: 10.1159/000464422.", "ArticleIdList": ["10.1159/000464422", "PMC5448443", "28588356"]}, {"Citation": "Kouli A., Torsney K.M., Kuan W.-L. Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects. Codon Publications; Brisbane, Australia: 2018. Parkinson\u2019s Disease: Etiology, Neuropathology, and Pathogenesis; pp. 3\u201326."}, {"Citation": "Maiti P., Manna J., Dunbar G.L., Maiti P., Dunbar G.L. Current understanding of the molecular mechanisms in Parkinson\u2019s disease: Targets for potential treatments. Transl. Neurodegener. 2017;6:28. doi: 10.1186/s40035-017-0099-z.", "ArticleIdList": ["10.1186/s40035-017-0099-z", "PMC5655877", "29090092"]}, {"Citation": "Michel P.P., Hirsch E.C., Hunot S. Understanding Dopaminergic Cell Death Pathways in Parkinson Disease. Neuron. 2016;90:675\u2013691. doi: 10.1016/j.neuron.2016.03.038.", "ArticleIdList": ["10.1016/j.neuron.2016.03.038", "27196972"]}, {"Citation": "G\u00f3mez-Benito M., Granado N., Garc\u00eda-Sanz P., Michel A., Dumoulin M., Moratalla R. Modeling Parkinson\u2019s Disease With the Alpha-Synuclein Protein. Front. Pharmacol. 2020;11:356. doi: 10.3389/fphar.2020.00356.", "ArticleIdList": ["10.3389/fphar.2020.00356", "PMC7191035", "32390826"]}, {"Citation": "Musuka T.D., Wilton S.B., Traboulsi M., Hill M.D. Diagnosis and management of acute ischemic stroke: Speed is critical. Can. Med. Assoc. J. 2015;187:887\u2013893. doi: 10.1503/cmaj.140355.", "ArticleIdList": ["10.1503/cmaj.140355", "PMC4562827", "26243819"]}, {"Citation": "Numis A.L., Fox C.K. Arterial ischemic stroke in children: Risk factors and etiologies. Curr. Neurol. Neurosci. Rep. 2014;14:422. doi: 10.1007/s11910-013-0422-8.", "ArticleIdList": ["10.1007/s11910-013-0422-8", "PMC3954544", "24384876"]}, {"Citation": "Guo Y., Li P., Guo Q., Shang K., Yan D., Du S., Lu Y. Pathophysiology and Biomarkers in Acute Ischemic Stroke\u2014A Review. Trop. J. Pharm. Res. 2014;12:1097\u20131105. doi: 10.4314/tjpr.v12i6.35.", "ArticleIdList": ["10.4314/tjpr.v12i6.35"]}, {"Citation": "Powers W.J., Rabinstein A.A., Ackerson T., Adeoye O.M., Bambakidis N.C., Becker K., Biller J., Brown M., Demaerschalk B.M., Hoh B., et al. Guidelines for the Early Management of Patients with Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50:E344\u2013E418.", "ArticleIdList": ["31662037"]}, {"Citation": "England M.J., Liverman C.T., Schultz A.M., Strawbridge L.M. Epilepsy across the spectrum: Promoting health and understanding. A summary of the Institute of Medicine report. Epilepsy Behav. 2012;25:266\u2013276. doi: 10.1016/j.yebeh.2012.06.016.", "ArticleIdList": ["10.1016/j.yebeh.2012.06.016", "PMC3548323", "23041175"]}, {"Citation": "Muhigwa A., Preux P.M., G\u00e9rard D., Marin B., Boumedi\u00e8ne F., Ntamwira C., Tsai C.H. Comorbidities of epilepsy in low and middle-income countries: Systematic review and meta-analysis. Sci. Rep. 2020;10:9015. doi: 10.1038/s41598-020-65768-6.", "ArticleIdList": ["10.1038/s41598-020-65768-6", "PMC7265529", "32488109"]}, {"Citation": "Pearson-Smith J.N., Patel M. Metabolic Dysfunction and Oxidative Stress in Epilepsy. Int. J. Mol. Sci. 2017;18:2635. doi: 10.3390/ijms18112365.", "ArticleIdList": ["10.3390/ijms18112365", "PMC5713334", "29117123"]}, {"Citation": "Hussain R., Zubair H., Pursell S., Shahab M. Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches. Brain Sci. 2018;8:177. doi: 10.3390/brainsci8090177.", "ArticleIdList": ["10.3390/brainsci8090177", "PMC6162719", "30223579"]}, {"Citation": "Ghorbanpour M., Varma A. Medicinal Plants and Environmental Challenges. Springer; Cham, Switzerland: 2017. Medicinal plants and environmental challenges; pp. 1\u2013413."}, {"Citation": "Balakrishnan R., Azam S., Cho D.Y., Su-Kim I., Choi D.K. Natural Phytochemicals as Novel Therapeutic Strategies to Prevent and Treat Parkinson\u2019s Disease: Current Knowledge and Future Perspectives. Oxid. Med. Cell. Longev. 2021;2021:6680935. doi: 10.1155/2021/6680935.", "ArticleIdList": ["10.1155/2021/6680935", "PMC8169248", "34122727"]}, {"Citation": "Lim H.W., Kumar H., Kim B.W., More S.V., Kim I.W., Park J.I., Park S.Y., Kim S.K., Choi D.K. \u03b2-Asarone (cis-2,4,5-trimethoxy-1-allyl phenyl), attenuates pro-inflammatory mediators by inhibiting NF-\u03baB signaling and the JNK pathway in LPS activated BV-2 microglia cells. Food Chem. Toxicol. 2014;72:265\u2013272. doi: 10.1016/j.fct.2014.07.018.", "ArticleIdList": ["10.1016/j.fct.2014.07.018", "25066769"]}, {"Citation": "Kim B.W., Koppula S., Kumar H., Park J.Y., Kim I.W., More S.V., Kim I.S., Han S.D., Kim S.K., Yoon S.H., et al. \u03b1-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson\u2019s disease. Neuropharmacology. 2015;97:46\u201357. doi: 10.1016/j.neuropharm.2015.04.037.", "ArticleIdList": ["10.1016/j.neuropharm.2015.04.037", "25983275"]}, {"Citation": "Lee H.J., Ahn S.M., Pak M.E., Jung D.H., Lee S.Y., Shin H.K., Choi B.T. Positive effects of \u03b1-asarone on transplanted neural progenitor cells in a murine model of ischemic stroke. Phytomedicine. 2018;51:151\u2013161. doi: 10.1016/j.phymed.2018.09.230.", "ArticleIdList": ["10.1016/j.phymed.2018.09.230", "30466612"]}, {"Citation": "Chellian R., Pandy V., Mohamed Z. Pharmacology and toxicology of \u03b1- and \u03b2-Asarone: A review of preclinical evidence. Phytomedicine. 2017;32:41\u201358. doi: 10.1016/j.phymed.2017.04.003.", "ArticleIdList": ["10.1016/j.phymed.2017.04.003", "28732807"]}, {"Citation": "Zeng L., Zhang D., Liu Q., Zhang J., Mu K., Gao X., Zhang K., Li H., Wang Q., Zheng Y. Alpha-asarone Improves Cognitive Function of APP/PS1 Mice and Reducing A\u03b2 42, P-tau and Neuroinflammation, and Promoting Neuron Survival in the Hippocampus. Neuroscience. 2021;458:141\u2013152. doi: 10.1016/j.neuroscience.2020.12.026.", "ArticleIdList": ["10.1016/j.neuroscience.2020.12.026", "33412244"]}, {"Citation": "Huang L., Deng M., He Y., Lu S., Liu S., Fang Y. \u03b2-asarone increases MEF2D and TH levels and reduces \u03b1-synuclein level in 6-OHDA-induced rats via regulating the HSP70/MAPK/MEF2D/Beclin-1 pathway: Chaperone-mediated autophagy activation, macroautophagy inhibition and HSP70 up-expression. Behav. Brain Res. 2016;313:370\u2013379. doi: 10.1016/j.bbr.2016.07.028.", "ArticleIdList": ["10.1016/j.bbr.2016.07.028", "27444243"]}, {"Citation": "Han T., Han P., Peng W., Wang X.R. Antidepressant-like effects of essential oil and asarone, a major essential oil component from the rhizome of Acorus tatarinowii. Pharm. Biol. 2013;51:589\u2013594. doi: 10.3109/13880209.2012.751616.", "ArticleIdList": ["10.3109/13880209.2012.751616", "23363070"]}, {"Citation": "Pa H., Xu Y., Cai Q., Wu M., Din M. Effects of \u03b2-Asarone on Ischemic Stroke in Middle Cerebral Artery Occlusion Rats by an Nrf2-Antioxidant Response Elements (ARE) Pathway-Dependent Mechanism. Med. Sci. Monit. 2021;27:e931884.", "ArticleIdList": ["PMC8186271", "34083500"]}, {"Citation": "Rajput S.B., Tonge M.B., Karuppayil S.M. An overview on traditional uses and pharmacological profile of Acorus calamus Linn. (Sweet flag) and other Acorus species. Phytomedicine. 2014;21:268\u2013276. doi: 10.1016/j.phymed.2013.09.020.", "ArticleIdList": ["10.1016/j.phymed.2013.09.020", "24200497"]}, {"Citation": "Chamorro G., Salazar M., Salazar S., Mendoza T. Pharmacology and toxicology of Guatteria gaumeri and alpha-asarone. Rev. Investig. Clin. 1993;45:597\u2013604. (In Spanish)", "ArticleIdList": ["8159883"]}, {"Citation": "Mukherjee P.K., Kumar V., Mal M., Houghton P.J. Acorus calamus: Scientific Validation of Ayurvedic Tradition from Natural Resources. Pharm. Biol. 2007;45:651\u2013666. doi: 10.1080/13880200701538724.", "ArticleIdList": ["10.1080/13880200701538724"]}, {"Citation": "Sharma V., Singh I., Chaudhary P. Acorus calamus (The Healing Plant): A review on its medicinal potential, micropropagation and conservation. Nat. Prod. Res. 2014;28:1454\u20131466. doi: 10.1080/14786419.2014.915827.", "ArticleIdList": ["10.1080/14786419.2014.915827", "24824923"]}, {"Citation": "Sharma V., Sharma R., Gautam D., Kuca K., Nepovimova E., Martins N. Role of Vacha (Acorus calamus Linn.) in Neurological and Metabolic Disorders: Evidence from Ethnopharmacology, Phytochemistry, Pharmacology and Clinical Study. J. Clin. Med. 2020;9:1176. doi: 10.3390/jcm9041176.", "ArticleIdList": ["10.3390/jcm9041176", "PMC7230970", "32325895"]}, {"Citation": "Muthuraman A., Singh N. Acute and sub-acute oral toxicity profile of Acorus calamus (Sweet flag) in rodents. Asian Pac. J. Trop. Biomed. 2012;2:S1017\u2013S1023. doi: 10.1016/S2221-1691(12)60354-2.", "ArticleIdList": ["10.1016/S2221-1691(12)60354-2"]}, {"Citation": "Muthuraman A., Singh N. Attenuating effect of Acorus calamus extract in chronic constriction injury induced neuropathic pain in rats: An evidence of anti-oxidative, anti-inflammatory, neuroprotective and calcium inhibitory effects. BMC Complement. Altern. Med. 2011;11:24. doi: 10.1186/1472-6882-11-24.", "ArticleIdList": ["10.1186/1472-6882-11-24", "PMC3072356", "21426568"]}, {"Citation": "Jain N., Jain R., Jain A., Jain D.K., Chandel H.S. Evaluation of wound-healing activity of Acorus calamus Linn. Nat. Prod. Res. 2010;24:534\u2013541. doi: 10.1080/14786410802531782.", "ArticleIdList": ["10.1080/14786410802531782", "20182947"]}, {"Citation": "Kim H., Han T.H., Lee S.G. Anti-inflammatory activity of a water extract of Acorus calamus L. leaves on keratinocyte HaCaT cells. J. Ethnopharmacol. 2009;122:149\u2013156. doi: 10.1016/j.jep.2008.12.011.", "ArticleIdList": ["10.1016/j.jep.2008.12.011", "19146941"]}, {"Citation": "Shu H., Zhang S., Lei Q., Zhou J., Ji Y., Luo B., Hong L., Li F., Liu B., Long C. Ethnobotany of Acorus in China. Acta Soc. Bot. Pol. 2018;87:3585. doi: 10.5586/asbp.3585.", "ArticleIdList": ["10.5586/asbp.3585"]}, {"Citation": "Sarjan H.N., Divyashree S., Yajurvedi H.N. The protective effect of the Vacha rhizome extract on chronic stress-induced immunodeficiency in rat. Pharm. Biol. 2017;55:1358. doi: 10.1080/13880209.2017.1301495.", "ArticleIdList": ["10.1080/13880209.2017.1301495", "PMC6130551", "28303736"]}, {"Citation": "Lam K.Y.C., Wu Q.Y., Hu W.H., Yao P., Wang H.Y., Dong T.T.X., Tsim K.W.K. Asarones from Acori tatarinowii Rhizoma stimulate expression and secretion of neurotrophic factors in cultured astrocytes. Neurosci. Lett. 2019;707:134308. doi: 10.1016/j.neulet.2019.134308.", "ArticleIdList": ["10.1016/j.neulet.2019.134308", "31153972"]}, {"Citation": "Das B.K., Choukimath S.M., Gadad P.C. Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu. Life Sci. 2019;230:10\u201318. doi: 10.1016/j.lfs.2019.05.046.", "ArticleIdList": ["10.1016/j.lfs.2019.05.046", "31121175"]}, {"Citation": "Das B.K., Swamy A.V., Koti B.C., Gadad P.C. Experimental evidence for use of Acorus calamus (asarone) for cancer chemoprevention. Heliyon. 2019;5:e01585. doi: 10.1016/j.heliyon.2019.e01585.", "ArticleIdList": ["10.1016/j.heliyon.2019.e01585", "PMC6513775", "31193009"]}, {"Citation": "Lee J.Y., Lee J.Y., Yun B.S., Hwang B.K. Antifungal Activity of \u03b2-Asarone from Rhizomes of Acorus gramineus. J. Agric. Food Chem. 2004;52:776\u2013780. doi: 10.1021/jf035204o.", "ArticleIdList": ["10.1021/jf035204o", "14969530"]}, {"Citation": "Wang N., Han Y., Luo L., Zhang Q., Ning B., Fang Y. \u03b2-asarone induces cell apoptosis, inhibits cell proliferation and decreases migration and invasion of glioma cells. Biomed. Pharmacother. 2018;106:655\u2013664. doi: 10.1016/j.biopha.2018.06.169.", "ArticleIdList": ["10.1016/j.biopha.2018.06.169", "29990855"]}, {"Citation": "Wu H.B., Fang Y.Q. Pharmacokinetics of \u03b2-asarone in rats. Acta Pharm. Sin. 2004;39:836\u2013838.", "ArticleIdList": ["15700827"]}, {"Citation": "Lu J., Fu T., Qian Y., Zhang Q., Zhu H., Pan L., Guo L., Zhang M. Distribution of \u03b1-asarone in brain following three different routes of administration in rats. Eur. J. Pharm. Sci. 2014;63:63\u201370. doi: 10.1016/j.ejps.2014.06.006.", "ArticleIdList": ["10.1016/j.ejps.2014.06.006", "25008114"]}, {"Citation": "Ren C., Gong T., Sun X., Zhang Z., Zhang Y. Alpha-Asarone incorporated in mixed micelles suitable for intravenous administration: Formulation, in-vivo distribution and anaphylaxis study. Pharmazie. 2011;66:875\u2013880.", "ArticleIdList": ["22204134"]}, {"Citation": "Liu L., Fang Y.Q. Analysis of the distribution of \u03b2-asarone in rat hippocampus, brainstem, cortex and cerebellum with gas chromatography-mass spectrometry (GC-MS) J. Med. Plants Res. 2011;5:1728\u20131734."}, {"Citation": "Meng X., Zhao X., Wang S., Jia P., Bai Y., Liao S., Zheng X. Simultaneous Determination of Volatile Constituents from Acorus tatarinowii Schott in Rat Plasma by Gas Chromatography-Mass Spectrometry with Selective Ion Monitoring and Application in Pharmacokinetic Study. J. Anal. Methods Chem. 2013;2013:949830. doi: 10.1155/2013/949830.", "ArticleIdList": ["10.1155/2013/949830", "PMC3855985", "24349826"]}, {"Citation": "Qian Y.Y., Lu J., Zhang L.H., Shi F.Y., Fu T.M., Guo L.W. Pharmacokinetic study on dry powder inhalation administration of \u03b1-asarone in rats. China J. Chin. Mater. Med. 2015;40:739\u2013743.", "ArticleIdList": ["26137700"]}, {"Citation": "Ramalingam P., Ganesan P., Prabakaran D.S., Gupta P.K., Jonnalagadda S., Govindarajan K., Vishnu R., Sivalingam K., Sodha S., Choi D.K., et al. Lipid Nanoparticles Improve the Uptake of \u03b1-Asarone Into the Brain Parenchyma: Formulation, Characterization, In Vivo Pharmacokinetics, and Brain Delivery. AAPS PharmSciTech. 2020;21:299. doi: 10.1208/s12249-020-01832-8.", "ArticleIdList": ["10.1208/s12249-020-01832-8", "33140227"]}, {"Citation": "Pan L., Zhou J., Ju F., Zhu H. Intranasal delivery of \u03b1-asarone to the brain with lactoferrin-modified mPEG-PLA nanoparticles prepared by premix membrane emulsification. Drug Deliv. Transl. Res. 2018;8:83\u201396. doi: 10.1007/s13346-017-0438-8.", "ArticleIdList": ["10.1007/s13346-017-0438-8", "29134552"]}, {"Citation": "Lu J., Guo L.W., Fu T.M., Zhu G.L., Dai Z.N., Zhan G.J., Chen L.L. Pharmacokinetics of \u03b1-asarone after intranasal and intravenous administration with PLA-\u03b1-asarone nanoparticles. China J. Chin. Mater. Med. 2017;42:2366\u20132372. (In Chinese)", "ArticleIdList": ["28822195"]}, {"Citation": "Wu J.Y., Li Y.J., Yang L., Hu Y.Y., Hu X.B., Tang T.T., Wang J.M., Liu X.Y., Xiang D.X. Borneol and a-asarone as adjuvant agents for improving blood-brain barrier permeability of puerarin and tetramethylpyrazine by activating adenosine receptors. Drug Deliv. 2018;25:1858\u20131864. doi: 10.1080/10717544.2018.1516005.", "ArticleIdList": ["10.1080/10717544.2018.1516005", "PMC6201807", "30338713"]}, {"Citation": "Gupta M., Kant K., Sharma R., Kumar A. Evaluation of In Silico Anti-parkinson Potential of \u03b2-asarone. Cent. Nerv. Syst. Agents Med. Chem. 2018;18:128\u2013135. doi: 10.2174/1871524918666180416153742.", "ArticleIdList": ["10.2174/1871524918666180416153742", "29658442"]}, {"Citation": "Fang Y.Q., Shi C., Liu L., Fang R.M. Pharmacokinetics of \u03b2-asarone in rabbit blood, hippocampus, cortex, brain stem, thalamus and cerebellum. Pharmazie. 2012;67:120\u2013123.", "ArticleIdList": ["22512081"]}, {"Citation": "Chen Q.X., Miao J.K., Li C., Li X.W., Wu X.M., Zhang X.P. Anticonvulsant activity of acute and chronic treatment with a-asarone from Acorus gramineus in seizure models. Biol. Pharm. Bull. 2013;36:23\u201330. doi: 10.1248/bpb.b12-00376.", "ArticleIdList": ["10.1248/bpb.b12-00376", "23075695"]}, {"Citation": "Morales-Ram\u00edrez P., Madrigal-Bujaidar E., Mercader-Mart\u00ednez J., Cassani M., Gonz\u00e1lez G., Chamorro-Cevallos G., Salazar-Jacobo M. Sister-chromatid exchange induction produced by in vivo and in vitro exposure to alpha-asarone. Mutat. Res. 1992;279:269\u2013273. doi: 10.1016/0165-1218(92)90243-S.", "ArticleIdList": ["10.1016/0165-1218(92)90243-S", "1377782"]}, {"Citation": "European Commision . Opinion of the Scientific Committee on Food on the Presence of \u03b2-Asarone in Flavourings and Other Food Ingredients with Flavouring Properties. European Commision; Brussels, Belgium: 2002. pp. 1\u201315."}, {"Citation": "Liu L., Wang J., Shi L., Zhang W., Du X., Wang Z., Zhang Y. \u03b2-Asarone induces senescence in colorectal cancer cells by inducing lamin B1 expression. Phytomedicine. 2013;20:512\u2013520. doi: 10.1016/j.phymed.2012.12.008.", "ArticleIdList": ["10.1016/j.phymed.2012.12.008", "23357361"]}, {"Citation": "Uebel T., Hermes L., Haupenthal S., M\u00fcller L., Esselen M. \u03b1-Asarone, \u03b2-asarone, and \u03b3-asarone: Current status of toxicological evaluation. J. Appl. Toxicol. 2021;41:1166\u20131179. doi: 10.1002/jat.4112.", "ArticleIdList": ["10.1002/jat.4112", "33236787"]}, {"Citation": "Manzanero S., Santro T., Arumugam T.V. Neuronal oxidative stress in acute ischemic stroke: Sources and contribution to cell injury. Neurochem. Int. 2013;62:712\u2013718. doi: 10.1016/j.neuint.2012.11.009.", "ArticleIdList": ["10.1016/j.neuint.2012.11.009", "23201332"]}, {"Citation": "Murray A.J., Rogers J.C., Katshu M.Z.U.H., Liddle P.F., Upthegrove R. Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders. Front. Psychiatry. 2021;12:703452. doi: 10.3389/fpsyt.2021.703452.", "ArticleIdList": ["10.3389/fpsyt.2021.703452", "PMC8339376", "34366935"]}, {"Citation": "Asha Devi S., Mali A.L., Rahee M.A., Belinda E.D.S. Antioxidant properties of Alpha asarone. Asian J. Biochem. 2014;9:107\u2013113. doi: 10.3923/ajb.2014.107.113.", "ArticleIdList": ["10.3923/ajb.2014.107.113"]}, {"Citation": "Parki A., Chaubey P., Prakash O., Kumar R., Pant A.K. Seasonal Variation in Essential Oil Compositions and Antioxidant Properties of Acorus calamus L. Accessions. Medicines. 2017;4:81. doi: 10.3390/medicines4040081.", "ArticleIdList": ["10.3390/medicines4040081", "PMC5750605", "29117116"]}, {"Citation": "Loying R., Gogoi R., Sarma N., Borah A., Munda S., Pandey S.K., Lal M. Chemical Compositions, In-vitro Antioxidant, Anti-microbial, Anti-inflammatory and Cytotoxic Activities of Essential Oil of Acorus calamus L. Rhizome from North-East India. J. Essent. Oil Bear. Plants. 2019;22:1299\u20131312. doi: 10.1080/0972060X.2019.1696236.", "ArticleIdList": ["10.1080/0972060X.2019.1696236"]}, {"Citation": "Pages N., Maurois P., Delplanque B., Bac P., Stables J.P., Tamariz J., Chamorro G., Vamecq J. Activities of \u03b1-asarone in various animal seizure models and in biochemical assays might be essentially accounted for by antioxidant properties. Neurosci. Res. 2010;68:337\u2013344. doi: 10.1016/j.neures.2010.08.011.", "ArticleIdList": ["10.1016/j.neures.2010.08.011", "20833211"]}, {"Citation": "Hei X., Xie M., Xu J., Li J., Liu T. \u03b2-Asarone Exerts Antioxidative Effects on H2O2-Stimulated PC12 Cells by Activating Nrf2/HO-1 Pathway. Neurochem. Res. 2020;45:1953\u20131961. doi: 10.1007/s11064-020-03060-9.", "ArticleIdList": ["10.1007/s11064-020-03060-9", "32623664"]}, {"Citation": "Meng M., Zhang L., AI D., Wu H., Peng W. \u03b2-Asarone Ameliorates \u03b2-Amyloid\u2013Induced Neurotoxicity in PC12 Cells by Activating P13K/Akt/Nrf2 Signaling Pathway. Front. Pharmacol. 2021;12:1079. doi: 10.3389/fphar.2021.659955.", "ArticleIdList": ["10.3389/fphar.2021.659955", "PMC8141729", "34040526"]}, {"Citation": "Lam K.Y.C., Yao P., Wang H., Duan R., Dong T.T.X., Tsim K.W.K. Asarone from Acori tatarinowii Rhizome prevents oxidative stress-induced cell injury in cultured astrocytes: A signaling triggered by Akt activation. PLoS ONE. 2017;12:e0179077. doi: 10.1371/journal.pone.0179077.", "ArticleIdList": ["10.1371/journal.pone.0179077", "PMC5466315", "28598994"]}, {"Citation": "Lam K.Y.C., Chen J., Lam C.T.W., Wu Q., Yao P., Dong T.T.X., Lin H., Tsim K.W.K. Asarone from Acori tatarinowii Rhizoma Potentiates the Nerve Growth Factor-Induced Neuronal Differentiation in Cultured PC12 Cells: A Signaling Mediated by Protein Kinase A. PLoS ONE. 2016;11:e0163337. doi: 10.1371/journal.pone.0163337.", "ArticleIdList": ["10.1371/journal.pone.0163337", "PMC5042514", "27685847"]}, {"Citation": "Sundaramahalingam M., Ramasundaram S., Rathinasamy S.D., Natarajan R.P., Somasundaram T. Role of Acorus calamus and alpha-asarone on hippocampal dependent memory in noise stress exposed rats. Pak. J. Biol. Sci. 2013;16:770\u2013778. doi: 10.3923/pjbs.2013.770.778.", "ArticleIdList": ["10.3923/pjbs.2013.770.778", "24498829"]}, {"Citation": "Kumar H., Kim B.W., Song S.Y., Kim J.S., Kim I.S., Kwon Y.S., Koppula S., Choi D.K. Cognitive enhancing effects of alpha asarone in amnesic mice by influencing cholinergic and antioxidant defense mechanisms. Biosci. Biotechnol. Biochem. 2012;76:1518\u20131522. doi: 10.1271/bbb.120247.", "ArticleIdList": ["10.1271/bbb.120247", "22878197"]}, {"Citation": "Chellian R., Pandy V., Mohamed Z. Alpha-asarone attenuates depression-like behavior in nicotine-withdrawn mice: Evidence for the modulation of hippocampal pCREB levels during nicotine-withdrawal. Eur. J. Pharmacol. 2018;818:10\u201316. doi: 10.1016/j.ejphar.2017.10.025.", "ArticleIdList": ["10.1016/j.ejphar.2017.10.025", "29042206"]}, {"Citation": "Saldanha A.A., Vieira L., de Oliveira F.M., Lopes D.d.O., Ribeiro R.I.M.d.A., Thom\u00e9 R.G., dos Santos H.B., Silva D.B., Carollo C.A., de Siqueira J.M., et al. Anti-inflammatory and central and peripheral anti-nociceptive activities of \u03b1-asarone through the inhibition of TNF-\u03b1 production, leukocyte recruitment and iNOS expression, and participation of the adenosinergic and opioidergic systems. Inflammopharmacology. 2020;28:1039\u20131052. doi: 10.1007/s10787-019-00679-1.", "ArticleIdList": ["10.1007/s10787-019-00679-1", "31865494"]}, {"Citation": "Li Q., Xu F., Zhang Q., Li X., Guo M., Zhang Y., Wang Z., Wang J., Zhao J., Tian Y., et al. Effect of \u03b1-asarone on ethanol-induced learning and memory impairment in mice and its underlying mechanism. Life Sci. 2019;238:116898. doi: 10.1016/j.lfs.2019.116898.", "ArticleIdList": ["10.1016/j.lfs.2019.116898", "31610193"]}, {"Citation": "Chen Y., Gao X., Liu Q., Zeng L., Zhang K., Mu K., Zhang D., Zou H., Wu N., Ou J., et al. Alpha-asarone improves cognitive function of aged rats by alleviating neuronal excitotoxicity via GABA A receptors. Neuropharmacology. 2020;162:107843. doi: 10.1016/j.neuropharm.2019.107843.", "ArticleIdList": ["10.1016/j.neuropharm.2019.107843", "31704273"]}, {"Citation": "Zou D.J., Wang G., Liu J.C., Dong M.X., Li X.M., Zhang C., Zhou L., Wang R., Niu Y.C. Beta-asarone attenuates beta-amyloid-induced apoptosis through the inhibition of the activation of apoptosis signal-regulating kinase 1 in SH-SY5Y cells. Pharmazie. 2011;66:44\u201351.", "ArticleIdList": ["21391434"]}, {"Citation": "Chang W., Teng J. \u03b2-asarone prevents A\u03b225-35-induced inflammatory responses and autophagy in SH-SY5Y cells: Down expression Beclin-1, LC3B and up expression Bcl-2. Int. J. Clin. Exp. Med. 2015;8:20658.", "ArticleIdList": ["PMC4723832", "26884987"]}, {"Citation": "Yang Y.X., Chen Y.T., Zhou X.J., Hong C.L., Li C.Y., Guo J.Y. Beta-asarone, a major component of Acorus tatarinowii Schott, attenuates focal cerebral ischemia induced by middle cerebral artery occlusion in rats. BMC Complement. Altern. Med. 2013;13:236. doi: 10.1186/1472-6882-13-236.", "ArticleIdList": ["10.1186/1472-6882-13-236", "PMC3853232", "24066702"]}, {"Citation": "Zhang K., Liu Q., Luo L., Feng X., Hu Q., Fan X., Mao S. Neuroprotective Effect of Alpha-asarone on the Rats Model of Cerebral Ischemia-Reperfusion Stroke via Ameliorating Glial Activation and Autophagy. Neuroscience. 2021;473:130\u2013141. doi: 10.1016/j.neuroscience.2021.08.006.", "ArticleIdList": ["10.1016/j.neuroscience.2021.08.006", "34416342"]}, {"Citation": "Deng M., Huang L., Zhong X. \u03b2-asarone modulates Beclin-1, LC3 and p62 expression to attenuate A\u03b240 and A\u03b242 levels in APP/PS1 transgenic mice with Alzheimer\u2019s disease. Mol. Med. Rep. 2020;21:2095\u20132102. doi: 10.3892/mmr.2020.11026.", "ArticleIdList": ["10.3892/mmr.2020.11026", "PMC7115210", "32186763"]}, {"Citation": "Xiao X., Xu X., Li F., Xie G., Zhang T. Anti-inflammatory treatment with \u03b2-asarone improves impairments in social interaction and cognition in MK-801 treated mice. Brain Res. Bull. 2019;150:150\u2013159. doi: 10.1016/j.brainresbull.2019.05.017.", "ArticleIdList": ["10.1016/j.brainresbull.2019.05.017", "31129169"]}, {"Citation": "Dong H., Gao Z., Rong H., Jin M., Zhang X. \u03b2-asarone reverses chronic unpredictable mild stress-induced depression-like behavior and promotes hippocampal neurogenesis in rats. Molecules. 2014;19:5634\u20135649. doi: 10.3390/molecules19055634.", "ArticleIdList": ["10.3390/molecules19055634", "PMC6270931", "24786848"]}, {"Citation": "Li C., Xing G., Dong M., Zhou L., Li J., Wang G., Zou D., Wang R., Liu J., Niu Y. Beta-asarone protection against beta-amyloid-induced neurotoxicity in PC12 cells via JNK signaling and modulation of Bcl-2 family proteins. Eur. J. Pharmacol. 2010;635:96\u2013102. doi: 10.1016/j.ejphar.2010.03.013.", "ArticleIdList": ["10.1016/j.ejphar.2010.03.013", "20307525"]}, {"Citation": "Zhang S., Gui X.H., Huang L.P., Deng M.Z., Fang R.M., Ke X.H., He Y.P., Li L., Fang Y.Q. Neuroprotective Effects of \u03b2-Asarone Against 6-Hydroxy Dopamine-Induced Parkinsonism via JNK/Bcl-2/Beclin-1 Pathway. Mol. Neurobiol. 2016;53:83\u201394. doi: 10.1007/s12035-014-8950-z.", "ArticleIdList": ["10.1007/s12035-014-8950-z", "25404088"]}, {"Citation": "Wei G., Chen Y.B., Chen D.F., Lai X.P., Liu D.H., Deng R.D., Zhou J.H., Zhang S.X., Li Y.W., Lii H., et al. \u03b2-Asarone inhibits neuronal apoptosis via the CaMKII/CREB/Bcl-2 signaling pathway in an in vitro model and A\u03b2PP/PS1 mice. J. Alzheimer\u2019s Dis. 2013;33:863\u2013880. doi: 10.3233/JAD-2012-120865.", "ArticleIdList": ["10.3233/JAD-2012-120865", "23064259"]}, {"Citation": "Saki G., Eidi A., Mortazavi P., Panahi N., Vahdati A. Effect of \u03b2-asarone in normal and \u03b2-amyloid-induced Alzheimeric rats. Arch. Med. Sci. 2020;16:699\u2013706. doi: 10.5114/aoms.2020.94659.", "ArticleIdList": ["10.5114/aoms.2020.94659", "PMC7212238", "32399120"]}, {"Citation": "Manikandan S., Devi R.S. Antioxidant property of alpha-asarone against noise-stress-induced changes in different regions of rat brain. Pharmacol. Res. 2005;52:467\u2013474. doi: 10.1016/j.phrs.2005.07.007.", "ArticleIdList": ["10.1016/j.phrs.2005.07.007", "16140022"]}, {"Citation": "Sandeep D., Nair C.K.K. Radioprotection by \u03b1-asarone: Prevention of genotoxicity and hematopoietic injury in mammalian organism. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2011;722:62\u201368. doi: 10.1016/j.mrgentox.2011.03.005.", "ArticleIdList": ["10.1016/j.mrgentox.2011.03.005", "21440084"]}, {"Citation": "Wang B.L., Xuan L., Dai S.J., Ji L.T., Li C.Y., Yang Y.X. Protective effect of \u03b2-asarone on AD rat model induced by intracerebroventricular injection of A\u03b2\u2081\u208b\u2084\u2082 combined 2-VO and its mechanism. China J. Chin. Mater. Med. 2017;42:4847\u20134854. (In Chinese)", "ArticleIdList": ["29493157"]}, {"Citation": "S\u00e1nchez-Alegr\u00eda K., Flores-Le\u00f3n M., Avila-Mu\u00f1oz E., Rodr\u00edguez-Corona N., Arias C. PI3K Signaling in Neurons: A Central Node for the Control of Multiple Functions. Int. J. Mol. Sci. 2018;19:3725. doi: 10.3390/ijms19123725.", "ArticleIdList": ["10.3390/ijms19123725", "PMC6321294", "30477115"]}, {"Citation": "Long H.Z., Cheng Y., Zhou Z.W., Luo H.Y., Wen D.D., Gao L.C. PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer\u2019s Disease and Parkinson\u2019s Disease. Front. Pharmacol. 2021;12:648636. doi: 10.3389/fphar.2021.648636.", "ArticleIdList": ["10.3389/fphar.2021.648636", "PMC8082498", "33935751"]}, {"Citation": "Sun J., Nan G. The extracellular signal-regulated kinase 1/2 pathway in neurological diseases: A potential therapeutic target (Review) Int. J. Mol. Med. 2017;39:1338\u20131346. doi: 10.3892/ijmm.2017.2962.", "ArticleIdList": ["10.3892/ijmm.2017.2962", "PMC5428947", "28440493"]}, {"Citation": "Naoi M., Shamoto-Nagai M., Maruyama W. Neuroprotection of multifunctional phytochemicals as novel therapeutic strategy for neurodegenerative disorders: Antiapoptotic and antiamyloidogenic activities by modulation of cellular signal pathways. Future Neurol. 2019;14:FNL9. doi: 10.2217/fnl-2018-0028.", "ArticleIdList": ["10.2217/fnl-2018-0028"]}, {"Citation": "Xue Z., Guo Y., Zhang S., Huang L., He Y., Fang R., Fang Y. Beta-asarone attenuates amyloid beta-induced autophagy via Akt/mTOR pathway in PC12 cells. Eur. J. Pharmacol. 2014;741:195\u2013204. doi: 10.1016/j.ejphar.2014.08.006.", "ArticleIdList": ["10.1016/j.ejphar.2014.08.006", "25160744"]}, {"Citation": "He Y., He J.N., Fu J., Bao Y.T., Li C.Y., Yang Y.X. Protective effect of \u03b2-asarone on PC12 cells injury induced by A\u03b2\u2081\u208b\u2084\u2082 astrocytic activation. China J. Chin. Mater. Med. 2016;41:1282\u20131288. (In Chinese)", "ArticleIdList": ["28879744"]}, {"Citation": "Mao J., Huang S., Liu S., Feng X.L., Yu M., Liu J., Sun Y.E., Chen G., Yu Y., Zhao J., et al. A herbal medicine for Alzheimer\u2019s disease and its active constituents promote neural progenitor proliferation. Aging Cell. 2015;14:784\u2013796. doi: 10.1111/acel.12356.", "ArticleIdList": ["10.1111/acel.12356", "PMC4568966", "26010330"]}, {"Citation": "Soto C., Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat. Neurosci. 2018;21:1332\u20131340. doi: 10.1038/s41593-018-0235-9.", "ArticleIdList": ["10.1038/s41593-018-0235-9", "PMC6432913", "30250260"]}, {"Citation": "Vasili E., Dominguez-Meijide A., Outeiro T.F. Spreading of \u03b1-synuclein and tau: A systematic comparison of the mechanisms involved. Front. Mol. Neurosci. 2019;12:107. doi: 10.3389/fnmol.2019.00107.", "ArticleIdList": ["10.3389/fnmol.2019.00107", "PMC6494944", "31105524"]}, {"Citation": "Kumar D., Kumar P. A\u03b2, Tau, and \u03b1-Synuclein aggregation and integrated role of PARK2 in the regulation and clearance of toxic peptides. Neuropeptides. 2019;78:101971. doi: 10.1016/j.npep.2019.101971.", "ArticleIdList": ["10.1016/j.npep.2019.101971", "31540705"]}, {"Citation": "Ciechanover A., Kwon Y.T. Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies. Exp. Mol. Med. 2015;47:e147. doi: 10.1038/emm.2014.117.", "ArticleIdList": ["10.1038/emm.2014.117", "PMC4351408", "25766616"]}, {"Citation": "Choi M.L., Gandhi S. Crucial role of protein oligomerization in the pathogenesis of Alzheimer\u2019s and Parkinson\u2019s diseases. FEBS J. 2018;285:3631\u20133644. doi: 10.1111/febs.14587.", "ArticleIdList": ["10.1111/febs.14587", "29924502"]}, {"Citation": "Nakamura T., Lipton S.A. Cell death: Protein misfolding and neurodegenerative diseases. Apoptosis. 2009;14:455\u2013468. doi: 10.1007/s10495-008-0301-y.", "ArticleIdList": ["10.1007/s10495-008-0301-y", "19130231"]}, {"Citation": "Sweeney P., Park H., Baumann M., Dunlop J., Frydman J., Kopito R., McCampbell A., Leblanc G., Venkateswaran A., Nurmi A. Protein misfolding in neurodegenerative diseases: Implications and strategies. Transl. Neurodegener. 2017;6:6. doi: 10.1186/s40035-017-0077-5.", "ArticleIdList": ["10.1186/s40035-017-0077-5", "PMC5348787", "28293421"]}, {"Citation": "Pietrobono D., Giacomelli C., Trincavelli M.L., Daniele S., Martini C. Inhibitors of protein aggregates as novel drugs in neurodegenerative diseases. Glob. Drugs Ther. 2017;2:1\u20135."}, {"Citation": "Bieschke J. Natural Compounds May Open New Routes to Treatment of Amyloid Diseases. Neurotherapeutics. 2013;10:429\u2013439. doi: 10.1007/s13311-013-0192-7.", "ArticleIdList": ["10.1007/s13311-013-0192-7", "PMC3701768", "23670234"]}, {"Citation": "Javed H., Nagoor Meeran M.F., Azimullah S., Adem A., Sadek B., Ojha S.K. Plant Extracts and Phytochemicals Targeting \u03b1-Synuclein Aggregation in Parkinson\u2019s Disease Models. Front. Pharmacol. 2019;9:1555. doi: 10.3389/fphar.2018.01555.", "ArticleIdList": ["10.3389/fphar.2018.01555", "PMC6433754", "30941047"]}, {"Citation": "Kabir M.T., Uddin M.S., Begum M.M., Thangapandiyan S., Rahman M.S., Aleya L., Mathew B., Ahmed M., Barreto G.E., Ashraf G.M. Cholinesterase Inhibitors for Alzheimer\u2019s Disease: Multitargeting Strategy Based on Anti-Alzheimer\u2019s Drugs Repositioning. Curr. Pharm. Des. 2019;25:3519\u20133535. doi: 10.2174/1381612825666191008103141.", "ArticleIdList": ["10.2174/1381612825666191008103141", "31593530"]}, {"Citation": "Shin J.W., Cheong Y.J., Koo Y.M., Kim S., Noh C.K., Son Y.H., Kang C., Sohn N.W. \u03b1-Asarone ameliorates memory deficit in lipopolysaccharide-treated mice via suppression of pro-inflammatory cytokines and microglial activation. Biomol. Ther. 2014;22:17\u201326. doi: 10.4062/biomolther.2013.102.", "ArticleIdList": ["10.4062/biomolther.2013.102", "PMC3936426", "24596617"]}, {"Citation": "Wang N., Wang H., Li L., Li Y., Zhang R. \u03b2-Asarone Inhibits Amyloid-\u03b2 by Promoting Autophagy in a Cell Model of Alzheimer\u2019s Disease. Front. Pharmacol. 2020;10:1529. doi: 10.3389/fphar.2019.01529.", "ArticleIdList": ["10.3389/fphar.2019.01529", "PMC6979317", "32009952"]}, {"Citation": "Lee J.E., Kim N., Yeo J.Y., Seo D.G., Kim S., Lee J.S., Hwang K.W., Park S.Y. Anti-Amyloidogenic Effects of Asarone Derivatives From Perilla frutescens Leaves against Beta-Amyloid Aggregation and Nitric Oxide Production. Molecules. 2019;24:4297. doi: 10.3390/molecules24234297.", "ArticleIdList": ["10.3390/molecules24234297", "PMC6930631", "31775356"]}, {"Citation": "Risiglione P., Zinghirino F., Di Rosa M.C., Magr\u00ec A., Messina A. Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson\u2019s Disease: The Emerging Role of VDAC. Biomolecules. 2021;11:718. doi: 10.3390/biom11050718.", "ArticleIdList": ["10.3390/biom11050718", "PMC8170894", "34064816"]}, {"Citation": "Moloney T.C., Hyland R., O\u2019Toole D., Paucard A., Kirik D., O\u2019Doherty A., Gorman A.M., Dowd E. Heat shock protein 70 reduces \u03b1-synuclein-induced predegenerative neuronal dystrophy in the \u03b1-synuclein viral gene transfer rat model of Parkinson\u2019s disease. CNS Neurosci. Ther. 2014;20:50\u201358. doi: 10.1111/cns.12200.", "ArticleIdList": ["10.1111/cns.12200", "PMC6493192", "24279716"]}, {"Citation": "Dong Z., Wolfer D.P., Lipp H.P., B\u00fceler H. Hsp70 gene transfer by adeno-associated virus inhibits MPTP-induced nigrostriatal degeneration in the mouse model of Parkinson disease. Mol. Ther. 2005;1:80\u201388. doi: 10.1016/j.ymthe.2004.09.007.", "ArticleIdList": ["10.1016/j.ymthe.2004.09.007", "15585408"]}, {"Citation": "Zhang Q.S., Wang Z.H., Zhang J.L., Duan Y.L., Li G.F., Zheng D.L. Beta-asarone protects against MPTP-induced Parkinson\u2019s disease via regulating long non-coding RNA MALAT1 and inhibiting \u03b1-synuclein protein expression. Biomed. Pharmacother. 2016;83:153\u2013159. doi: 10.1016/j.biopha.2016.06.017.", "ArticleIdList": ["10.1016/j.biopha.2016.06.017", "27470562"]}, {"Citation": "Lehman N.L. The ubiquitin proteasome system in neuropathology. Acta Neuropathol. 2009;118:329\u2013347. doi: 10.1007/s00401-009-0560-x.", "ArticleIdList": ["10.1007/s00401-009-0560-x", "PMC2716447", "19597829"]}, {"Citation": "Cook C., Stetler C., Petrucelli L. Disruption of protein quality control in Parkinson\u2019s disease. Cold Spring Harb. Perspect. Med. 2012;2:a009423. doi: 10.1101/cshperspect.a009423.", "ArticleIdList": ["10.1101/cshperspect.a009423", "PMC3331692", "22553500"]}, {"Citation": "Sprenkle N.T., Sims S.G., S\u00e1nchez C.L., Meares G.P. Endoplasmic reticulum stress and inflammation in the central nervous system. Mol. Neurodegener. 2017;12:42. doi: 10.1186/s13024-017-0183-y.", "ArticleIdList": ["10.1186/s13024-017-0183-y", "PMC5445486", "28545479"]}, {"Citation": "Sano R., Reed J.C. ER stress-induced cell death mechanisms. Biochim. Biophys. Acta. 2013;1833:3460\u20133470. doi: 10.1016/j.bbamcr.2013.06.028.", "ArticleIdList": ["10.1016/j.bbamcr.2013.06.028", "PMC3834229", "23850759"]}, {"Citation": "Rao R.V., Bredesen D.E. Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. Curr. Opin. Cell Biol. 2004;16:653\u2013662. doi: 10.1016/j.ceb.2004.09.012.", "ArticleIdList": ["10.1016/j.ceb.2004.09.012", "PMC3970707", "15530777"]}, {"Citation": "H\u00f8yer-Hansen M., J\u00e4\u00e4ttel\u00e4 M. Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ. 2007;14:1576\u20131582. doi: 10.1038/sj.cdd.4402200.", "ArticleIdList": ["10.1038/sj.cdd.4402200", "17612585"]}, {"Citation": "Yang H., Niemeijer M., van de Water B., Beltman J.B. ATF6 Is a Critical Determinant of CHOP Dynamics during the Unfolded Protein Response. iScience. 2020;23:100860. doi: 10.1016/j.isci.2020.100860.", "ArticleIdList": ["10.1016/j.isci.2020.100860", "PMC7005498", "32058971"]}, {"Citation": "Ryu E.J., Harding H.P., Angelastro J.M., Vitolo O.V., Ron D., Greene L.A. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson\u2019s disease. J. Neurosci. 2002;22:10690\u201310698. doi: 10.1523/JNEUROSCI.22-24-10690.2002.", "ArticleIdList": ["10.1523/JNEUROSCI.22-24-10690.2002", "PMC6758450", "12486162"]}, {"Citation": "Jiang P., Gan M., Ebrahim A.S., Lin W.L., Melrose H.L., Yen S.H.C. ER stress response plays an important role in aggregation of \u03b1-synuclein. Mol. Neurodegener. 2010;5:56. doi: 10.1186/1750-1326-5-56.", "ArticleIdList": ["10.1186/1750-1326-5-56", "PMC3016345", "21144044"]}, {"Citation": "Holtz W.A., Turetzky J.M., Jong Y.J.I., O\u2019Malley K.L. Oxidative stress-triggered unfolded protein response is upstream of intrinsic cell death evoked by parkinsonian mimetics. J. Neurochem. 2006;99:54\u201369. doi: 10.1111/j.1471-4159.2006.04025.x.", "ArticleIdList": ["10.1111/j.1471-4159.2006.04025.x", "16987235"]}, {"Citation": "Ning B., Deng M., Zhang Q., Wang N., Fang Y. \u03b2-Asarone Inhibits IRE1/XBP1 Endoplasmic Reticulum Stress Pathway in 6-OHDA-Induced Parkinsonian Rats. Neurochem. Res. 2016;41:2097\u20132101. doi: 10.1007/s11064-016-1922-0.", "ArticleIdList": ["10.1007/s11064-016-1922-0", "27097550"]}, {"Citation": "Hotamisligil G.S. Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease. Cell. 2010;140:900\u2013917. doi: 10.1016/j.cell.2010.02.034.", "ArticleIdList": ["10.1016/j.cell.2010.02.034", "PMC2887297", "20303879"]}, {"Citation": "Ning B., Zhang Q., Wang N., Deng M., Fang Y. \u03b2-Asarone Regulates ER Stress and Autophagy Via Inhibition of the PERK/CHOP/Bcl-2/Beclin-1 Pathway in 6-OHDA-Induced Parkinsonian Rats. Neurochem. Res. 2019;44:1159\u20131166. doi: 10.1007/s11064-019-02757-w.", "ArticleIdList": ["10.1007/s11064-019-02757-w", "30796752"]}, {"Citation": "Park S.H., Kang M.K., Choi Y.J., Kim Y.H., Antika L.D., Lim S.S., Kang Y.H. Dietary compound \u03b1-asarone alleviates ER stress-mediated apoptosis in 7\u03b2-hydroxycholesterol-challenged macrophages. Mol. Nutr. Food Res. 2016;60:1033\u20131047. doi: 10.1002/mnfr.201500750.", "ArticleIdList": ["10.1002/mnfr.201500750", "26893256"]}, {"Citation": "Gui Y., Li A., Zhang J., Li G., Ruan X., Guo Q., Zou W. \u03b1-Asarone alleviated chronic constriction injury\u2013induced neuropathic pain through inhibition of spinal endoplasmic reticulum stress in an liver X receptor\u2013dependent manner. Anesth. Analg. 2018;127:775\u2013783. doi: 10.1213/ANE.0000000000002792.", "ArticleIdList": ["10.1213/ANE.0000000000002792", "29324503"]}, {"Citation": "Mikami M., Takuya O., Yoshino Y., Nakamura S., Ito K., Kojima H., Takahashi T., Iddamalgoda A., Inoue S., Shimazawa M. Acorus calamus extract and its component \u03b1-asarone attenuate murine hippocampal neuronal cell death induced by l-glutamate and tunicamycin. Biosci. Biotechnol. Biochem. 2021;85:493\u2013501. doi: 10.1093/bbb/zbaa071.", "ArticleIdList": ["10.1093/bbb/zbaa071", "33589895"]}, {"Citation": "Park H., Kang J.H., Lee S. Autophagy in Neurodegenerative Diseases: A Hunter for Aggregates. Int. J. Mol. Sci. 2020;21:3369. doi: 10.3390/ijms21093369.", "ArticleIdList": ["10.3390/ijms21093369", "PMC7247013", "32397599"]}, {"Citation": "Rahman M.A., Rahman M.R., Zaman T., Uddin M.S., Islam R., Abdel-Daim M.M., Rhim H. Emerging Potential of Naturally Occurring Autophagy Modulators Against Neurodegeneration. Curr. Pharm. Des. 2020;26:772\u2013779. doi: 10.2174/1381612826666200107142541.", "ArticleIdList": ["10.2174/1381612826666200107142541", "31914904"]}, {"Citation": "Ahsan A., Liu M., Zheng Y., Yan W., Pan L., Li Y., Ma S., Zhang X., Cao M., Wu Z., et al. Natural compounds modulate the autophagy with potential implication of stroke. Acta Pharm. Sin. B. 2021;11:1708\u20131720. doi: 10.1016/j.apsb.2020.10.018.", "ArticleIdList": ["10.1016/j.apsb.2020.10.018", "PMC8343111", "34386317"]}, {"Citation": "Park S.H., Kang M.K., Choi Y.J., Kim Y.H., Antika L.D., Kim D.Y., Lee E.J., Lim S.S., Kang Y.H. \u03b1-Asarone blocks 7\u03b2-hydroxycholesterol-exposed macrophage injury through blocking elF2\u03b1 phosphorylation and prompting beclin-1-dependent autophagy. Oncotarget. 2017;8:7370\u20137383. doi: 10.18632/oncotarget.14566.", "ArticleIdList": ["10.18632/oncotarget.14566", "PMC5352328", "28088783"]}, {"Citation": "Harry G.J., Kraft A.D. Microglia in the developing brain: A potential target with lifetime effects. Neurotoxicology. 2012;33:191\u2013206. doi: 10.1016/j.neuro.2012.01.012.", "ArticleIdList": ["10.1016/j.neuro.2012.01.012", "PMC3299893", "22322212"]}, {"Citation": "Jeong H.-K., Ji K., Min K., Joe E.-H. Brain inflammation and microglia: Facts and misconceptions. Exp. Neurobiol. 2013;22:59\u201367. doi: 10.5607/en.2013.22.2.59.", "ArticleIdList": ["10.5607/en.2013.22.2.59", "PMC3699675", "23833554"]}, {"Citation": "Lyman M., Lloyd D.G., Ji X., Vizcaychipi M.P., Ma D. Neuroinflammation: The role and consequences. Neurosci. Res. 2014;79:1\u201312. doi: 10.1016/j.neures.2013.10.004.", "ArticleIdList": ["10.1016/j.neures.2013.10.004", "24144733"]}, {"Citation": "Liu C.Y., Wang X., Liu C., Zhang H.L. Pharmacological Targeting of Microglial Activation: New Therapeutic Approach. Front. Cell. Neurosci. 2019;13:514. doi: 10.3389/fncel.2019.00514.", "ArticleIdList": ["10.3389/fncel.2019.00514", "PMC6877505", "31803024"]}, {"Citation": "Bachiller S., Jim\u00e9nez-Ferrer I., Paulus A., Yang Y., Swanberg M., Deierborg T., Boza-Serrano A. Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response. Front. Cell. Neurosci. 2018;12:488. doi: 10.3389/fncel.2018.00488.", "ArticleIdList": ["10.3389/fncel.2018.00488", "PMC6305407", "30618635"]}, {"Citation": "Fatoba O., Itokazu T., Yamashita T. Microglia as therapeutic target in central nervous system disorders. J. Pharmacol. Sci. 2020;144:102\u2013118. doi: 10.1016/j.jphs.2020.07.004.", "ArticleIdList": ["10.1016/j.jphs.2020.07.004", "32921391"]}, {"Citation": "Moussa C., Hebron M., Huang X., Ahn J., Rissman R.A., Aisen P.S., Turner R.S. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer\u2019s disease. J. Neuroinflamm. 2017;14:61. doi: 10.1186/s12974-016-0779-0.", "ArticleIdList": ["10.1186/s12974-016-0779-0", "PMC5234138", "28086917"]}, {"Citation": "Kaur N., Chugh H., Sakharkar M.K., Dhawan U., Chidambaram S.B., Chandra R. Neuroinflammation Mechanisms and Phytotherapeutic Intervention: A Systematic Review. ACS Chem. Neurosci. 2020;11:3707\u20133731. doi: 10.1021/acschemneuro.0c00427.", "ArticleIdList": ["10.1021/acschemneuro.0c00427", "33146995"]}, {"Citation": "Liu H.J., Lai X., Xu Y., Miao J.K., Li C., Liu J.Y., Hua Y.Y., Ma Q., Chen Q. \u03b1-Asarone Attenuates Cognitive Deficit in a Pilocarpine-Induced Status Epilepticus Rat Model via a Decrease in the Nuclear Factor-\u03baB Activation and Reduction in Microglia Neuroinflammation. Front. Neurol. 2017;8:661. doi: 10.3389/fneur.2017.00661.", "ArticleIdList": ["10.3389/fneur.2017.00661", "PMC5735142", "29312110"]}, {"Citation": "Jo M.J., Kumar H., Joshi H.P., Choi H., Ko W.K., Kim J.M., Hwang S.S.S., Park S.Y., Sohn S., Bello A.B., et al. Oral Administration of \u03b1-Asarone Promotes Functional Recovery in Rats With Spinal Cord Injury. Front. Pharmacol. 2018;9:445. doi: 10.3389/fphar.2018.00445.", "ArticleIdList": ["10.3389/fphar.2018.00445", "PMC5949368", "29867457"]}, {"Citation": "Cai Q., Li Y., Mao J., Pei G. Neurogenesis-promoting natural product \u03b1-asarone modulates morphological dynamics of activated microglia. Front. Cell. Neurosci. 2016;10:280. doi: 10.3389/fncel.2016.00280.", "ArticleIdList": ["10.3389/fncel.2016.00280", "PMC5145874", "28018174"]}, {"Citation": "Reichardt L.F. Neurotrophin-regulated signalling pathways. Philos. Trans. R. Soc. B Biol. Sci. 2006;361:1545. doi: 10.1098/rstb.2006.1894.", "ArticleIdList": ["10.1098/rstb.2006.1894", "PMC1664664", "16939974"]}, {"Citation": "Zhang H., Ozbay F., Lappalainen J., Kranzler H.R., Van Dyck C.H., Charney D.S., Price L.H., Southwick S., Yang B.Z., Rasmussen A., et al. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer\u2019s disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 2006;141:387\u2013393. doi: 10.1002/ajmg.b.30332.", "ArticleIdList": ["10.1002/ajmg.b.30332", "PMC2567822", "16649215"]}, {"Citation": "Kumar Gupta V., Sharma B. Role of Phytochemicals in Neurotrophins Mediated Regulation of Alzheimer\u2019s Disease. Int. J. Complement. Altern. Med. 2017;7:00231."}, {"Citation": "Maswood N., Grondin R., Zhang Z., Stanford J.A., Surgener S.P., Gash D.M., Gerhardt G.A. Effects of chronic intraputamenal infusion of glial cell line-derived neurotrophic factor (GDNF) in aged Rhesus monkeys. Neurobiol. Aging. 2002;23:881\u2013889. doi: 10.1016/S0197-4580(02)00022-2.", "ArticleIdList": ["10.1016/S0197-4580(02)00022-2", "12392792"]}, {"Citation": "Grondin R., Zhang Z., Yi A., Cass W.A., Maswood N., Andersen A.H., Elsberry D.D., Klein M.C., Gerhardt G.A., Gash D.M. Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain. 2002;125:2191\u20132201. doi: 10.1093/brain/awf234.", "ArticleIdList": ["10.1093/brain/awf234", "12244077"]}, {"Citation": "Grondin R., Cass W.A., Zhang Z., Stanford J.A., Gash D.M., Gerhardt G.A. Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys. J. Neurosci. 2003;23:1974\u20131980. doi: 10.1523/JNEUROSCI.23-05-01974.2003.", "ArticleIdList": ["10.1523/JNEUROSCI.23-05-01974.2003", "PMC6741972", "12629203"]}, {"Citation": "Stahl K., Mylonakou M.N., Stahl K., Amiry-Moghaddam M., Torp R. Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson\u2019s disease. Brain Res. 2011;1378:105\u2013118. doi: 10.1016/j.brainres.2010.12.090.", "ArticleIdList": ["10.1016/j.brainres.2010.12.090", "21236244"]}, {"Citation": "Takeda M. Intrathecal infusion of brain-derived neurotrophic factor protects nigral dopaminergic neurons from degenerative changes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced monkey parkinsonian model. Hokkaido J. Med. Sci. 1995;70:829\u2013838.", "ArticleIdList": ["8582706"]}, {"Citation": "Cui X., Lin Q., Liang Y. Plant-Derived Antioxidants Protect the Nervous System From Aging by Inhibiting Oxidative Stress. Front. Aging Neurosci. 2020;12:209. doi: 10.3389/fnagi.2020.00209.", "ArticleIdList": ["10.3389/fnagi.2020.00209", "PMC7372124", "32760268"]}, {"Citation": "Dong H., Cong W., Guo X., Wang Y., Tong S., Li Q., Li C. \u03b2-asarone relieves chronic unpredictable mild stress induced depression by regulating the extracellular signal-regulated kinase signaling pathway. Exp. Ther. Med. 2019;18:3767\u20133774. doi: 10.3892/etm.2019.8018.", "ArticleIdList": ["10.3892/etm.2019.8018", "PMC6781814", "31616508"]}, {"Citation": "Lee B., Sur B., Cho S.G., Yeom M., Shim I., Lee H., Hahm D.H. Effect of beta-asarone on impairment of spatial working memory and apoptosis in the hippocampus of rats exposed to chronic corticosterone administration. Biomol. Ther. 2015;23:571\u2013581. doi: 10.4062/biomolther.2015.027.", "ArticleIdList": ["10.4062/biomolther.2015.027", "PMC4624074", "26535083"]}, {"Citation": "Naoi M., Maruyama W., Shamoto-Nagai M. Type A monoamine oxidase and serotonin are coordinately involved in depressive disorders: From neurotransmitter imbalance to impaired neurogenesis. J. Neural Transm. 2018;125:53\u201366. doi: 10.1007/s00702-017-1709-8.", "ArticleIdList": ["10.1007/s00702-017-1709-8", "28293733"]}, {"Citation": "Finberg J.P.M., Rabey J.M. Inhibitors of MAO-A and MAO-B in psychiatry and neurology. Front. Pharmacol. 2016;7:340. doi: 10.3389/fphar.2016.00340.", "ArticleIdList": ["10.3389/fphar.2016.00340", "PMC5067815", "27803666"]}, {"Citation": "Huang L., Deng M., Fang Y., Li L. Dynamic changes of five neurotransmitters and their related enzymes in various rat tissues following \u03b2-asarone and levodopa co-administration. Exp. Ther. Med. 2015;10:1566\u20131572. doi: 10.3892/etm.2015.2704.", "ArticleIdList": ["10.3892/etm.2015.2704", "PMC4578043", "26622527"]}, {"Citation": "Huang L., Deng M., Zhang S., Fang Y., Li L. Coadministration of \u03b2-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: A different mechanism from Madopar. Clin. Exp. Pharmacol. Physiol. 2014;41:685\u2013690.", "ArticleIdList": ["24910244"]}, {"Citation": "Huang L., Deng M., Zhang S., Lu S., Gui X., Fang Y. \u03b2-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson\u2019s rat by enhancing dopa decarboxylase activity. Biomed. Pharmacother. 2017;94:666\u2013678. doi: 10.1016/j.biopha.2017.07.125.", "ArticleIdList": ["10.1016/j.biopha.2017.07.125", "28787702"]}, {"Citation": "Yang Q.Q., Xue W.Z., Zou R.X., Xu Y., Du Y., Wang S., Xu L., Chen Y.Z., Wang H.L., Chen X.T. \u03b2-Asarone Rescues Pb-Induced Impairments of Spatial Memory and Synaptogenesis in Rats. PLoS ONE. 2016;11:e0167401. doi: 10.1371/journal.pone.0167401.", "ArticleIdList": ["10.1371/journal.pone.0167401", "PMC5147873", "27936013"]}, {"Citation": "Jim\u00e9nez-Balado J., Eich T.S. GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer\u2019s disease. Semin. Cell Dev. Biol. 2021;116:146\u2013159. doi: 10.1016/j.semcdb.2021.01.005.", "ArticleIdList": ["10.1016/j.semcdb.2021.01.005", "PMC8292162", "33573856"]}, {"Citation": "Jakaria M., Park S.Y., Haque M., Karthivashan G., Kim I.S., Ganesan P., Choi D.K. Neurotoxic agent-induced injury in neurodegenerative disease model: Focus on involvement of glutamate receptors. Front. Mol. Neurosci. 2018;11:307. doi: 10.3389/fnmol.2018.00307.", "ArticleIdList": ["10.3389/fnmol.2018.00307", "PMC6123546", "30210294"]}, {"Citation": "Martin L.J. Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases. Pharmaceuticals. 2010;3:839\u2013915. doi: 10.3390/ph3040839.", "ArticleIdList": ["10.3390/ph3040839", "PMC3023298", "21258649"]}, {"Citation": "Wu Y., Chen M., Jiang J. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion. 2019;49:35\u201345. doi: 10.1016/j.mito.2019.07.003.", "ArticleIdList": ["10.1016/j.mito.2019.07.003", "31288090"]}, {"Citation": "Cho J., Ho Kim Y., Kong J.Y., Ha Yang C., Gook Park C. Protection of cultured rat cortical neurons from excitotoxicity by asarone, a major essential oil component in the rhizomes of Acorus gramineus. Life Sci. 2002;71:591\u2013599. doi: 10.1016/S0024-3205(02)01729-0.", "ArticleIdList": ["10.1016/S0024-3205(02)01729-0", "12052443"]}, {"Citation": "Irie Y., Keung W.M. Rhizoma Acori graminei and its active principles protect PC-12 cells from the toxic effect of amyloid-beta peptide. Brain Res. 2003;963:282\u2013289. doi: 10.1016/S0006-8993(02)04050-7.", "ArticleIdList": ["10.1016/S0006-8993(02)04050-7", "12560134"]}, {"Citation": "Tatton W.G., Olanow C.W. Apoptosis in neurodegenerative diseases: The role of mitochondria. Biochim. Biophys. Acta BBA\u2014Bioenerg. 1999;1410:195\u2013213. doi: 10.1016/S0005-2728(98)00167-4.", "ArticleIdList": ["10.1016/S0005-2728(98)00167-4", "10076027"]}, {"Citation": "KA J. Cell death mechanisms in neurodegeneration. J. Cell. Mol. Med. 2001;5:1\u201317.", "ArticleIdList": ["PMC6737760", "12067447"]}, {"Citation": "Fan J., Dawson T.M., Dawson V.L. Cell Death Mechanisms of Neurodegeneration. Adv. Neurobiol. 2017;15:403\u2013425.", "ArticleIdList": ["28674991"]}, {"Citation": "Geng Y., Li C., Liu J., Xing G., Zhou L., Dong M., Li X., Niu Y. Beta-asarone improves cognitive function by suppressing neuronal apoptosis in the beta-amyloid hippocampus injection rats. Biol. Pharm. Bull. 2010;33:836\u2013843. doi: 10.1248/bpb.33.836.", "ArticleIdList": ["10.1248/bpb.33.836", "20460763"]}, {"Citation": "Yin Y., She H., Li W., Yang Q., Guo S., Mao Z. Modulation of Neuronal Survival Factor MEF2 by Kinases in Parkinson\u2019s Disease. Front. Physiol. 2012;3:171. doi: 10.3389/fphys.2012.00171.", "ArticleIdList": ["10.3389/fphys.2012.00171", "PMC3362091", "22661957"]}, {"Citation": "She H., Yang Q., Shepherd K., Smith Y., Miller G., Testa C., Mao Z. Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients. J. Clin. Investig. 2011;121:930\u2013940. doi: 10.1172/JCI43871.", "ArticleIdList": ["10.1172/JCI43871", "PMC3049386", "21393861"]}, {"Citation": "Smith P.D., Mount M.P., Shree R., Callaghan S., Slack R.S., Anisman H., Vincent I., Wang X., Mao Z., Park D.S. Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. J. Neurosci. 2006;26:440\u2013447. doi: 10.1523/JNEUROSCI.2875-05.2006.", "ArticleIdList": ["10.1523/JNEUROSCI.2875-05.2006", "PMC6674390", "16407541"]}, {"Citation": "Yi Z., Li Z., Yu S., Yuan C., Hong W., Wang Z., Cui J., Shi T., Fang Y. Blood-Based Gene Expression Profiles Models for Classification of Subsyndromal Symptomatic Depression and Major Depressive Disorder. PLoS ONE. 2012;7:e31283. doi: 10.1371/journal.pone.0031283.", "ArticleIdList": ["10.1371/journal.pone.0031283", "PMC3278427", "22348066"]}, {"Citation": "Qi X., Lin W., Li J., Pan Y., Wang W. The depressive-like behaviors are correlated with decreased phosphorylation of mitogen-activated protein kinases in rat brain following chronic forced swim stress. Behav. Brain Res. 2006;175:233\u2013240. doi: 10.1016/j.bbr.2006.08.035.", "ArticleIdList": ["10.1016/j.bbr.2006.08.035", "17050000"]}, {"Citation": "Vogt A., Tamewitz A., Skoko J., Sikorski R.P., Giuliano K.A., Lazo J.S. The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1. J. Biol. Chem. 2005;280:19078\u201319086. doi: 10.1074/jbc.M501467200.", "ArticleIdList": ["10.1074/jbc.M501467200", "15753082"]}, {"Citation": "Duric V., Banasr M., Licznerski P., Schmidt H.D., Stockmeier C.A., Simen A.A., Newton S.S., Duman R.S. A negative regulator of MAP kinase causes depressive behavior. Nat. Med. 2010;16:1328\u20131332. doi: 10.1038/nm.2219.", "ArticleIdList": ["10.1038/nm.2219", "PMC3066515", "20953200"]}, {"Citation": "Sun Y.R., Wang W., Li S.S., Dong H.Y., Zhang X.J. \u03b2-asarone from Acorus gramineus alleviates depression by modulating MKP-1. Genet. Mol. Res. 2015;14:4495\u20134504. doi: 10.4238/2015.May.4.7.", "ArticleIdList": ["10.4238/2015.May.4.7", "25966222"]}, {"Citation": "Chellian R., Pandy V., Mohamed Z. Biphasic Effects of \u03b1-Asarone on Immobility in the Tail Suspension Test: Evidence for the Involvement of the Noradrenergic and Serotonergic Systems in Its Antidepressant-Like Activity. Front. Pharmacol. 2016;7:72. doi: 10.3389/fphar.2016.00072.", "ArticleIdList": ["10.3389/fphar.2016.00072", "PMC4811860", "27065863"]}, {"Citation": "Liu S., Chen S.W., Xu N., Liu X.H., Zhang H., Wang Y.Z., Xu X.D. Anxiolytic-like effect of \u03b1-asarone in mice. Phytother. Res. 2012;26:1476\u20131481. doi: 10.1002/ptr.4596.", "ArticleIdList": ["10.1002/ptr.4596", "22294454"]}, {"Citation": "Lee B., Sur B., Yeom M., Shim I., Lee H., Hahm D.H. Alpha-Asarone, a Major Component of Acorus gramineus, Attenuates Corticosterone-Induced Anxiety-Like Behaviours via Modulating TrkB Signaling Process. Korean J. Physiol. Pharmacol. 2014;18:191\u2013200. doi: 10.4196/kjpp.2014.18.3.191.", "ArticleIdList": ["10.4196/kjpp.2014.18.3.191", "PMC4071171", "24976758"]}, {"Citation": "He X., Bai Y., Zeng M., Zhao Z., Zhang Q., Xu N., Qin F., Wei X., Zhao M., Wu N., et al. Anticonvulsant activities of \u03b1-asaronol ((E)-3\u2032-hydroxyasarone), an active constituent derived from \u03b1-asarone. Pharmacol. Rep. 2018;70:69\u201374. doi: 10.1016/j.pharep.2017.08.004.", "ArticleIdList": ["10.1016/j.pharep.2017.08.004", "29331789"]}, {"Citation": "Ma W.C., Zhang Q., Li H., Chu T., Shi H.Y., Mao S.J. Literature review and cause analysis of adverse reactions caused by asarone injection. Chin. J. Pharmacovigil. 2010;7:243\u2013246."}, {"Citation": "Yang H.Y., Deng Y.P. Literature analysis of 122 adverse drug reactions induced by asarone injection. Chin. J. Ethnomed. Ethnopharm. 2012;6:36\u201339."}, {"Citation": "Guan Y.M., Liu J., Zhang J.L., Chen L.H., Zhu W.F., Zang Z.Z., Jin C., Wu L. Preparation and evaluation of four kinds of mixed essential oil liposomes in Jieyu Anshen Formula. China J. Chin. Mater. Med. 2019;44:1363\u20131370. (In Chinese)", "ArticleIdList": ["31090293"]}, {"Citation": "Lungare S., Hallam K., Badhan R.K.S. Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery. Int. J. Pharm. 2016;513:280\u2013293. doi: 10.1016/j.ijpharm.2016.09.042.", "ArticleIdList": ["10.1016/j.ijpharm.2016.09.042", "27633279"]}, {"Citation": "FAO . Joint FAO/WHO Expert Committee on Food Additives (JECFA) FAO; Rome, Italy: 1987."}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "10", "Day": "27"}, {"Year": "2022", "Month": "1", "Day": "23"}, {"Year": "2022", "Month": "1", "Day": "28"}, {"Year": "2022", "Month": "2", "Day": "25", "Hour": "1", "Minute": "3"}, {"Year": "2022", "Month": "2", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "26", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "1", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["35204164", "PMC8868500", "10.3390/antiox11020281", "antiox11020281"]}}], "PubmedBookArticle": []}